Publications in collaboration with researchers from Fundación Jiménez Díaz (2)

2023

  1. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A

    Signal Transduction and Targeted Therapy, Vol. 8, Núm. 1

2022

  1. A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

    Nature Communications, Vol. 13, Núm. 1